Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 691 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
26 Results
Pivotal Response Treatment for Children With Autism Spectrum Disorders (PRT)
- Child Development & Autism
- Genetics
- Mental Health & Behavioral Research
- Gender:All Genders
- Age:4 years - 35 years
DSB2455-001: Phase Ia/Ib Open Label, Multi-Centre Dose Escalation Study with Expansion Cohorts to Assess the Safety, Tolerability, and Activity of DSB2455 as Monotherapy in Participants with Advanced Malignancies (WCG local)
- Phase 1 Cancers
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in Triple Negative Breast Cancer (TNBC)
- Breast Cancer
- Gender:Female only
- Age:18 years and older
An Open-Label, Phase I/II First-in-Human, Dose Escalation, Dose Optimisation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumor Activity of IPN60300 as Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Phase 1 Cancers
Phase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
- Stomach & Esophagus
- Liver Cancer
- Gastrointestinal Cancers
- Pancreatic Cancer
- Colorectal Cancer
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- Prostate Cancer
A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)
- Lung Cancer
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
- HIV/AIDS
- Immune System
- Infectious Disease
- Gender:All Genders
- Age:18 years and older
A Phase 2, Randomized, Open-label, Study of Momelotinib in Participants With Anemia Due to Low-risk Myelodysplastic Syndrome
- Leukemia & Hematologic Cancers
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis
- Colorectal Cancer
- Stomach & Esophagus
1-10 of 26 Results